VANISH: Ablation reduces shock burden compared with anti-arrhythmic drug in ventricular tachycardia Presented ByProf. Michelle Samuel, University of Montreal, Canada TrialVANISH ConferenceEHRA 2022 1 June, 2022 10:26
Valsartan seems to attenuate hypertrophic cardiomyopathy progression Presented ByProf. Carolyn Ho, Brigham and Women’s Hospital, USA TrialPhase 2, VANISH ConferenceESC 2021 26 October, 2021 14:41